Certara Services Archives

Press Coverage Video

FDA Support Drives Shift Toward Bayesian Trial Design

Explore how Bayesian statistical methods are reshaping clinical trial design. Learn how FDA support, adaptive…

Danielle PillsburyMarch 13, 2026

Press Coverage

Single Pivotal Trials Demand Stronger Data and Risk Strategies

As regulators increasingly accept single pivotal trials for drug approval, sponsors must strengthen data quality,…

CertaraMarch 13, 2026

Blog

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Explore how model-informed drug development and AI are advancing pharmacoequity and shaping the future of…

CertaraMarch 11, 2026

Press Coverage Video

Advancing Bayesian Methods in Clinical Trials

Explore how Bayesian statistical methods are reshaping clinical trial design. Learn how FDA support, adaptive…

CertaraMarch 9, 2026

Blog

Pharmacovigilance Aggregate Reporting in China

Learn best practices for China pharmacovigilance aggregate reporting, with expert support and regulatory guidance insights.

CertaraMarch 6, 2026

Blog

DIA RSIDM 2026: From Doing Digital to Being Data-Driven

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= March 5, 2026 The atmosphere at this year's DIA RSIDM conference was defined by…

CertaraMarch 5, 2026

Publication

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer

This study used model-based meta-analysis (MBMA) to assess how well objective response rate (ORR) predicts…

Danielle PillsburyMarch 4, 2026

Conference

Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development

Danielle PillsburyMarch 2, 2026

Fact Sheet

Document Quality and Management

Ensure submission readiness with Certara’s Document Quality services. We deliver compliant, inspection-ready regulatory documents that…

CertaraFebruary 27, 2026

Fact Sheet

Safety & Pharmacovigilance Writing

Expertly delivering Safety & Pharmacovigilance Writing services, including Aggregate Safety Reports, Risk Management Plans, and…

CertaraFebruary 27, 2026

Certara Services

FDA Support Drives Shift Toward Bayesian Trial Design

Single Pivotal Trials Demand Stronger Data and Risk Strategies

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Advancing Bayesian Methods in Clinical Trials

Pharmacovigilance Aggregate Reporting in China

DIA RSIDM 2026: From Doing Digital to Being Data-Driven

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer

Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development

Document Quality and Management

Safety & Pharmacovigilance Writing

Newsletter sign up

Quick links

Solutions

Contact